Bioqual Shares Outstanding 2010-2024 | BIOQ
Bioqual shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Bioqual Annual Shares Outstanding
(Millions of Shares) |
| 2024 |
1 |
| 2023 |
1 |
| 2022 |
1 |
| 2021 |
1 |
| 2020 |
1 |
| 2019 |
1 |
| 2018 |
1 |
| 2017 |
1 |
| 2016 |
1 |
| 2015 |
1 |
| 2013 |
1 |
| 2012 |
1 |
| 2011 |
1 |
| 2010 |
1 |
| 2009 |
1 |
Bioqual Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-08-31 |
1 |
| 2024-05-31 |
1 |
| 2024-02-29 |
1 |
| 2023-11-30 |
1 |
| 2023-08-31 |
1 |
| 2023-05-31 |
1 |
| 2023-02-28 |
1 |
| 2022-11-30 |
1 |
| 2022-08-31 |
1 |
| 2022-05-31 |
1 |
| 2022-02-28 |
1 |
| 2021-11-30 |
1 |
| 2021-08-31 |
1 |
| 2021-05-31 |
1 |
| 2021-02-28 |
1 |
| 2020-11-30 |
1 |
| 2020-08-31 |
1 |
| 2020-05-31 |
1 |
| 2020-02-29 |
1 |
| 2019-11-30 |
1 |
| 2019-08-31 |
1 |
| 2019-05-31 |
1 |
| 2019-02-28 |
1 |
| 2018-11-30 |
1 |
| 2018-08-31 |
1 |
| 2018-05-31 |
1 |
| 2018-02-28 |
1 |
| 2017-11-30 |
1 |
| 2017-08-31 |
1 |
| 2017-05-31 |
1 |
| 2017-02-28 |
1 |
| 2016-11-30 |
1 |
| 2016-08-31 |
1 |
| 2016-05-31 |
1 |
| 2016-02-29 |
1 |
| 2015-11-30 |
1 |
| 2015-08-31 |
1 |
| 2015-05-31 |
1 |
| 2015-02-28 |
1 |
| 2014-08-31 |
1 |
| 2014-05-31 |
1 |
| 2013-11-30 |
1 |
| 2013-08-31 |
1 |
| 2013-05-31 |
1 |
| 2012-05-31 |
1 |
| 2012-02-29 |
1 |
| 2011-11-30 |
1 |
| 2011-08-31 |
1 |
| 2011-05-31 |
1 |
| 2011-02-28 |
1 |
| 2010-11-30 |
1 |
| 2010-08-31 |
1 |
| 2010-05-31 |
1 |
| 2010-02-28 |
1 |
| 2009-11-30 |
1 |
| 2009-08-31 |
1 |
| 2009-05-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.059B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
